Immunopharmacologic Analysis of an Autologous, Hapten-Modified Human Melanoma Vaccine

2003145 citationsJournal Articlebronze Open Access

Authors

David Berd · Thomas Jefferson University

Takami Sato · Thomas Jefferson University

Henry Maguire · Thomas Jefferson University

John C. Kairys · Thomas Jefferson University

Michael J. Mastrangelo · Thomas Jefferson University

Abstract

This study underscores the importance of the immunopharmacology of the autologous, DNP-modified vaccine and may be relevant to other cancer vaccine technologies.

Topics & Keywords

Immunotherapy and Immune Responses T-cell and B-cell Immunology vaccines and immunoinformatics approaches

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Clinical Oncology

Volume 22, Issue 3, pp. 403-415

DOI: 10.1200/jco.2004.06.043

Field-Weighted Citation Impact: 2.56